Drug-Drug Interaction and Safety of AZD4041 Study (Part 1) and Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of AZD4041 Study in Opioid Use Disorder (Part 2).
Clinical trial NCT06406400 · TERMINATED
Trial details
- NCT number
- NCT06406400
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-13
- Primary completion
- 2024-07-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.